Companies

Phase Biolabs

phasebiolabs.com

Phase Biolabs retrofits industrial plants with fermentation technology that converts waste CO₂ into chemicals and e-fuels.

HQNottingham, Not applicable (non-US), United Kingdom
Employees1-50
1 active role
Jobs checked 4d ago
Specialization
Biotechnology
Business
Hardware Manufacturingand 1 more business values
  • Scientific Research
Market
Manufacturingand 2 more market values
  • Energy
  • Environmental Services
Ecosystem
Not applicable
Customers
Enterprises
More details
Organization type
Commercial Company
Ecosystem
Not applicable
Business
Hardware Manufacturing, Scientific Research
Specialization
Biotechnology
Market
Manufacturing, Energy, Environmental Services
Customers
Enterprises
Delivery models
Hardware, Professional Services
Revenue models
Not classified
Listing status
Not classified
Latest equity round
Seed
Reported funding amount
Not classified

About

Phase Biolabs builds patented biotechnology and bolt-on fermentation systems that retrofit existing industrial plants, converting waste CO₂ into ethanol, chemicals, and e-fuels. Its customers are industrial plant operators and producers; its key differentiator is using emissions directly with minimal processing and without requiring carbon-capture technology, turning a waste stream into a revenue-generating asset.

Market

Phase Biolabs competes in industrial carbon capture, utilization and recycling, using synthetic biology and gas fermentation to convert industrial CO₂ into commodity chemicals, solvents, ethanol and e-fuels. Its positioning emphasizes a bolt-on retrofit for existing plants, direct use of emissions with minimal processing, and revenue generation from waste CO₂ rather than requiring a standalone carbon-capture system. The competitive set includes biological gas-fermentation companies such as LanzaTech and Arkeon, as well as adjacent CO₂-to-products platforms such as Twelve and Solugen.

Target Customers

Large industrial CO₂ emitters—especially existing bioethanol and chemical-manufacturing plants—that can install a separate retrofit unit and want to monetize emissions; likely buyers include plant owners, operations teams, and sustainability/decarbonization leaders. Secondary customers include chemical distributors and downstream manufacturers seeking low-carbon chemicals.

At a Glance

Problem

Phase Biolabs addresses the industrial problem of CO₂ emissions that are currently treated as a waste stream, cost, or compliance burden rather than as a feedstock. Its proposition is especially relevant to ethanol producers: much of the CO₂ generated by existing plants is vented, while producers face pressure to lower carbon intensity and secure better economics through advanced-biofuel pricing, low-carbon fuel credits, and emerging alcohol-to-jet markets.

The principal use case is retrofitting an existing grain-ethanol plant so its off-gas can be converted into additional ethanol. Phase’s illustrative model shows the potential economics: for a plant emitting 300,000 tonnes of CO₂ annually, the retrofit could produce 45 million additional gallons of ethanol and $42.3 million in modeled new revenue, assuming a $1.75-per-gallon ethanol price and including D5 RINs. These are company-model assumptions rather than demonstrated commercial results.

Product / Service

Phase develops a gas-fermentation platform using proprietary, genetically engineered microbial biocatalysts. Its three-step process prepares the gas, ferments the CO₂ into ethanol, and separates the product. The company says the process uses emissions directly with minimal processing, requires no separate carbon-capture technology, and can be installed as a bolt-on unit without disrupting the customer's existing plant.

The delivery model is a licensable retrofit: Phase licenses the technology and supplies the biocatalyst, while the industrial producer operates the production asset and retains the resulting output and upside. The benefit is a way to turn an emissions stream into more product and revenue while reducing process carbon intensity. Phase is also developing a broader platform for carbon-negative chemicals and e-fuels beyond its initial ethanol application.

Market

Phase competes in carbon capture and utilisation, industrial biotechnology, gas fermentation, low-carbon ethanol, and CO₂-derived fuels and chemicals. Its initial target market is sizeable by industrial standards: Phase says the global ethanol industry includes more than 800 plants, with the majority of their CO₂ currently vented. Relevant competitors and alternative approaches include LanzaTech, which uses gas fermentation to produce ethanol from industrial emissions and reports six commercial facilities, and Twelve, which converts CO₂ into products such as sustainable aviation fuel using renewable electricity.

Phase was founded in 2020, joined Y Combinator’s Winter 2022 batch, and reports support from Breakthrough Energy and Transition. It operates a small pilot plant in Nottingham, uses that facility to collect continuous performance data, and has reported pilot ethanol yields above 80%. It has partnership agreements involving biogenic CO₂ and renewable hydrogen and is seeking partners and a location for a commercial demonstration plant. The evidence therefore indicates a funded, pilot-stage and pre-commercial company rather than one with established commercial revenue or a full-scale operating plant.

Founders & Leadership

David OrtegaFounder
Founder & CEO

Funding History

2020-09
SBRI Phase 1 grant£40K

Innovate UK (SBRI)

2022-03
Seed$500K

Transition, Y Combinator

Recent News

2026-07-29product_launch
So you want to use plants to reduce CO₂

A recent Hacker News discussion featuring Phase Biolabs describes a lab-scale 1.5L bioreactor containing a microorganism that consumes carbon dioxide and hydrogen gas. The available snippet truncates before identifying the resulting products.

2026-04-10partnership
Welcome to Our New Member, Phase Biolabs!

CO2 Value Europe announced Phase Biolabs as a new member and described its focus on converting waste CO₂ into valuable chemicals and electrofuels through carbon capture and utilisation. The announcement says Phase Biolabs is seeking EU/UK partners and locations for a commercial demonstration plant.

Active Roles

1
Nottingham/Engineering/78d ago

Business Model

Phase Biolabs appears to pursue a B2B industrial-technology model, commercializing retrofit gas-fermentation systems for industrial plants through customer deployments and commercial partnerships. Its public materials do not disclose specific pricing, licensing terms, or recurring revenue arrangements.

Products

CO₂-to-ethanol gas-fermentation systemCO₂-derived carbon-neutral chemicals and solventsCO₂-derived carbon-neutral or carbon-negative e-fuels/electrofuelsTurn-key carbon-capture-utilization retrofit platform for existing industrial plants

Customers

Alcohols LimitedCambridge Display Technology

Tech Stack

Gas fermentationEngineered microbial biocatalystsSynthetic biology and genetic engineeringAI-assisted biocatalyst designDirect CO₂ utilization with minimal processingBolt-on industrial process integration

Competitors

LanzaTech
Solugen
Twelve
Arkeon Biotechnologies